Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
| ▸ | S100A4 | P26447 | 2/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | PTPRC | P08575 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | CA7 | P43166 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.54 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.54 |
| ▸ | GSK3B | P49841 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.44 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30050991 | 1.00 | SMN1; SMN2 (0.61) | SMN1; SMN2S100A4POLBKMT2AMEN1 | |
| Methane SCHEMBL28163541 | 0.98 | SMN1; SMN2 (0.60) | SMN1; SMN2S100A4POLBKMT2AMEN1 | |
| SCHEMBL28012557 | 0.98 | SMN1; SMN2 (0.60) | SMN1; SMN2S100A4POLBKMT2AMEN1 | |
| SCHEMBL9453359 | 0.88 | POLB (0.58) | SMN1; SMN2S100A4POLBKMT2AMEN1 | |
| SCHEMBL11669701 | 0.84 | S100A4 (0.56) | SMN1; SMN2S100A4POLBKMT2AMEN1 | |
| SCHEMBL29260825 | 0.84 | SMN1; SMN2 (0.48) | SMN1; SMN2S100A4POLBKMT2AMEN1 | |
| Ethoxycarbonyl Group SCHEMBL28473867 | 0.83 | SMN1; SMN2 (0.47) | SMN1; SMN2S100A4POLBKMT2AMEN1 | |
| SCHEMBL1049963 | 0.80 | PARP1 (0.56) | SMN1; SMN2S100A4POLBKMT2AMEN1 | |
| SCHEMBL9453357 | 0.78 | SMN1; SMN2 (0.51) | SMN1; SMN2S100A4POLBKMT2AMEN1 | |
| SCHEMBL27307007 | 0.78 | ALDH1A1 (0.58) | SMN1; SMN2S100A4POLBKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 828 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118995043-B | Polymer insulation coating material for high-voltage transmission line and preparation method thereof | 河北冀特电气有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-119076058-A | Carbon intercalation iron phthalocyanine heterogeneous junction and preparation method and application thereof | 南京大学 | 2024-12-06 | — | — | CN | claimed |
| CN-118995043-A | Polymer insulation coating material for high-voltage transmission line and preparation method thereof | 河北冀特电气有限公司 | 2024-11-22 | — | — | CN | claimed |
| US-20240383909-A1 | CO-CRYSTALS | INTRA-CELLULAR THERAPIES, INC. | 2024-11-21 | — | — | US | claimed |
| CN-118496072-A | Method for preparing 2-butanone by biomimetic catalytic oxidation of n-butane | 浙江工业大学 | 2024-08-16 | — | — | CN | claimed |
| US-20240228475-A1 | PROCESSES FOR THE PREPARATION OF (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE | CELGENE CORPORATION | 2024-07-11 | — | — | US | claimed |
| EP-4395767-A2 | CO-CRYSTALS | Intra-Cellular Therapies, Inc. (US) | 2024-07-10 | — | — | EP | claimed |
| CN-118146084-A | Method for preparing benzoic acid and coproducing epsilon-caprolactone by biomimetically catalyzing air to oxidize toluene and cyclohexanone | 广西大学 | 2024-06-07 | — | — | CN | claimed |
| EP-4359380-A1 | PROCESSES FOR THE PREPARATION OF (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL) METHYL)BENZYL) AMINO)ISOINDOLINE-1,3-DIONE | Celgene Corporation (US) | 2024-05-01 | — | — | EP | claimed |
| CN-117645638-A | Fullerene derivative, and preparation method and application thereof | 中国科学院化学研究所 | 2024-03-05 | — | — | CN | claimed |
| WO-1985002613-A1 | DESTRUCTION OF DNPI IN AN ALL NITRIC ACID NITRATION PROCESS | GENERAL ELECTRIC COMPANY (US) | 1985-06-20 | — | — | WO | claimed |
| US-4455431-A | Method for making bis-etherphthalimides | GENERAL ELECTRIC COMPANY (US) | 1984-06-19 | — | — | US | claimed |
| US-4308341-A | PROVIDING ISOINDOZE DYES BY REACTION OF COBALT AMINE LIGANDS AND AROMATIC DIALDEHYDES | EASTMAN KODAK COMPANY (US) | 1981-12-29 | — | — | US | claimed |
| US-4181530-A | ELECTRON ATTRACTING PHTHALIMIDE | FUJI PHOTO FILM CO., LTD. (JP) | 1980-01-01 | — | — | US | claimed |
| US-4054577-A | Preparation of aromatic bisimides | GENERAL ELECTRIC COMPANY (US) | 1977-10-18 | — | — | US | claimed |
| US-4020069-A | FROM BISPHENOL A AND A NITRO-PHTHALIMIDE, HYDROLYSIS | GENERAL ELECTRIC COMPANY (US) | 1977-04-26 | — | — | US | claimed |
| US-4017511-A | Preparation of aromatic bisimides | GENERAL ELECTRIC COMPANY (US) | 1977-04-12 | — | — | US | claimed |
| US-3992406-A | Preparation of aromatic bisimides | GENERAL ELECTRIC COMPANY (US) | 1976-11-16 | — | — | US | claimed |
| US-3957862-A | FROM A NITRO-PHTHALIMIDE AND ALKALI DIPHENOXIDE | GENERAL ELECTRIC COMPANY (US) | 1976-05-18 | — | — | US | claimed |
| US-3933852-A | Process for making N-methyl nitrophthalimides | GENERAL ELECTRIC COMPANY (US) | 1976-01-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240383909-A1 | CO-CRYSTALS | NT5C3B, PRNP, MTAP | SMN1; SMN2 4001/4885S100A4 1111/4885POLB 3169/4885 |
| US-20240228475-A1 | PROCESSES FOR THE PREPARATION OF (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE | AQP1, AQP3, ADH1C | SMN1; SMN2 738/4885S100A4 3456/4885POLB 601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.